Clinical Surveillance Possible in Classical Hodgkin Lymphoma After Remission

Share this content:

the Cancer Therapy Advisor take:

When patients with classical Hodgkin lymphoma (cHL) achieve complete remission after frontline therapy, they can either undergo clinical surveillance or routine surveillance imaging. According to a study published in Cancer and partly presented at the 2014 American Society of Clinical Oncology Annual Meeting, there was not a significant difference in survival rate for patients who underwent clinical surveillance and those who underwent routine surveillance imaging.

 

Sai Ravi Pingali, MD, and researchers at the University of Nebraska analyzed 241 patients who were diagnosed with cHL and achieved complete remission after frontline therapy. The 174 patients in the routine surveillance imaging group underwent computed tomography and/or positron emission tomography scans. The 67 patients in the clinical surveillance group underwent clinical examinations, laboratory studies, and scans that were only taken due to concerning signs or symptoms. 

 

After 5 years, the results showed that the routine surveillance imaging group had an overall survival rate of 97% while the clinical surveillance group had an overall survival rate of 9%. Although there were a few relapses, the relapsed patients in both groups achieved complete remission after second-line therapy.

 

The study indicated that although routine surveillance imaging has higher imaging-related costs, its clinical benefit is on par with clinical surveillance.

Abbreviated Protocol Feasible in Breast Cancer MRI Screening
Clinical Surveillance Possible in Classical Hodgkin Lymphoma After Remission

The objective of this study was to compare the outcomes of patients with classical Hodgkin lymphoma (cHL) who achieved complete remission with frontline therapy and then underwent either clinical surveillance or routine surveillance imaging.

In total, 241 patients who were newly diagnosed with cHL between January 2000 and December 2010 at 3 participating tertiary care centers and achieved complete remission after first-line therapy were retrospectively analyzed. Of these, there were 174 patients in the routine surveillance imaging group and 67 patients in the clinical surveillance group, based on the intended mode of surveillance.

READ FULL ARTICLE From Wiley Online Library

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs